219 related articles for article (PubMed ID: 20368082)
21. Apolipoprotein E genotypes and metabolic risk factors for coronary heart disease in middle-aged women.
Cubrilo-Turek M; Stavljenić-Rukavina A; Sertić J; Zrinski R; Turek S; Grgac G; Ljubojević N
Coll Antropol; 1998 Jun; 22(1):149-55. PubMed ID: 10097431
[TBL] [Abstract][Full Text] [Related]
22. Association between LDL-cholesterol, statin therapy, physical activity and inflammatory markers in patients with stable coronary heart disease.
König D; Deibert P; Winkler K; Berg A
Exerc Immunol Rev; 2005; 11():97-107. PubMed ID: 16385847
[TBL] [Abstract][Full Text] [Related]
23. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
[TBL] [Abstract][Full Text] [Related]
24. The apoB100/apoAI ratio is independently associated with the severity of coronary heart disease: a cross sectional study in patients undergoing coronary angiography.
Song Y; Yang Y; Zhang J; Wang Y; He W; Zhang X; Zhu J; Lu Z
Lipids Health Dis; 2015 Nov; 14():150. PubMed ID: 26582246
[TBL] [Abstract][Full Text] [Related]
25. Distribution of ApoA-I-containing HDL subpopulations in patients with coronary heart disease.
Asztalos BF; Roheim PS; Milani RL; Lefevre M; McNamara JR; Horvath KV; Schaefer EJ
Arterioscler Thromb Vasc Biol; 2000 Dec; 20(12):2670-6. PubMed ID: 11116070
[TBL] [Abstract][Full Text] [Related]
26. Association of High-Density Lipoprotein-Cholesterol Versus Apolipoprotein A-I With Risk of Coronary Heart Disease: The European Prospective Investigation Into Cancer-Norfolk Prospective Population Study, the Atherosclerosis Risk in Communities Study, and the Women's Health Study.
van Capelleveen JC; Bochem AE; Boekholdt SM; Mora S; Hoogeveen RC; Ballantyne CM; Ridker PM; Sun W; Barter PJ; Tall AR; Zwinderman AH; Kastelein JJP; Wareham NJ; Khaw KT; Hovingh GK
J Am Heart Assoc; 2017 Aug; 6(8):. PubMed ID: 28775061
[TBL] [Abstract][Full Text] [Related]
27. Associations of HDL phospholipids and paraoxonase activity with coronary heart disease in postmenopausal women.
Horter MJ; Sondermann S; Reinecke H; Bogdanski J; Woltering A; Kerber S; Breithardt G; Assmann G; Von Eckardstein A
Acta Physiol Scand; 2002 Oct; 176(2):123-30. PubMed ID: 12354172
[TBL] [Abstract][Full Text] [Related]
28. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
[TBL] [Abstract][Full Text] [Related]
29. High-density lipoprotein oxidation in type 2 diabetic patients and young patients with premature myocardial infarction.
Sartore G; Seraglia R; Burlina S; Bolis A; Marin R; Manzato E; Ragazzi E; Traldi P; Lapolla A
Nutr Metab Cardiovasc Dis; 2015 Apr; 25(4):418-25. PubMed ID: 25636381
[TBL] [Abstract][Full Text] [Related]
30. Serum amyloid A and high density lipoprotein participate in the acute phase response of Kawasaki disease.
Cabana VG; Gidding SS; Getz GS; Chapman J; Shulman ST
Pediatr Res; 1997 Nov; 42(5):651-5. PubMed ID: 9357939
[TBL] [Abstract][Full Text] [Related]
31. Value of HDL cholesterol, apolipoprotein A-I, lipoprotein A-I, and lipoprotein A-I/A-II in prediction of coronary heart disease: the PRIME Study. Prospective Epidemiological Study of Myocardial Infarction.
Luc G; Bard JM; Ferrières J; Evans A; Amouyel P; Arveiler D; Fruchart JC; Ducimetière P
Arterioscler Thromb Vasc Biol; 2002 Jul; 22(7):1155-61. PubMed ID: 12117731
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory markers modify the risk of recurrent coronary events associated with apolipoprotein A-I in postinfarction patients.
Wang M; Corsetti J; McNitt S; Rich DQ; Sparks CE; Moss AJ; Zareba W
J Clin Lipidol; 2017; 11(1):215-223. PubMed ID: 28391888
[TBL] [Abstract][Full Text] [Related]
33. Lipid assessment, metabolic syndrome and coronary heart disease risk.
Arsenault BJ; Després JP; Stroes ES; Wareham NJ; Kastelein JJ; Khaw KT; Boekholdt SM
Eur J Clin Invest; 2010 Dec; 40(12):1081-93. PubMed ID: 20701625
[TBL] [Abstract][Full Text] [Related]
34. Significant interaction of APOE rs4420638 polymorphism with HDL-C and APOA-I levels in coronary heart disease in Han Chinese men.
Huang Y; Ye HD; Gao X; Nie S; Hong QX; Ji HH; Sun J; Zhou SJ; Fei B; Li KQ; Zhao JK; Wang ZP; Xu MQ; Duan SW
Genet Mol Res; 2015 Oct; 14(4):13414-24. PubMed ID: 26535656
[TBL] [Abstract][Full Text] [Related]
35. Expression of serum amyloid A protein in the absence of the acute phase response does not reduce HDL cholesterol or apoA-I levels in human apoA-I transgenic mice.
Hosoai H; Webb NR; Glick JM; Tietge UJ; Purdom MS; de Beer FC; Rader DJ
J Lipid Res; 1999 Apr; 40(4):648-53. PubMed ID: 10191288
[TBL] [Abstract][Full Text] [Related]
36. Serum triglyceride, high-density lipoprotein cholesterol, apolipoprotein B, and coronary heart disease in a Chinese population undergoing coronary angiography.
Ling Y; Jiang J; Wu B; Gao X
J Clin Lipidol; 2017; 11(3):646-656. PubMed ID: 28506386
[TBL] [Abstract][Full Text] [Related]
37. Ezetimibe decreases serum amyloid A levels in HDL3 in hemodialysis patients.
Hirano T; Nohtomi K; Nakanishi N; Watanabe T; Hyodo T; Taira T
Clin Nephrol; 2010 Oct; 74(4):282-7. PubMed ID: 20875380
[TBL] [Abstract][Full Text] [Related]
38. Effects of serum amyloid A on the structure and antioxidant ability of high-density lipoprotein.
Sato M; Ohkawa R; Yoshimoto A; Yano K; Ichimura N; Nishimori M; Okubo S; Yatomi Y; Tozuka M
Biosci Rep; 2016 Aug; 36(4):. PubMed ID: 27422844
[TBL] [Abstract][Full Text] [Related]
39. SAA-only HDL formed during the acute phase response in apoA-I+/+ and apoA-I-/- mice.
Cabana VG; Reardon CA; Wei B; Lukens JR; Getz GS
J Lipid Res; 1999 Jun; 40(6):1090-103. PubMed ID: 10357841
[TBL] [Abstract][Full Text] [Related]
40. Apolipoprotein B/apolipoprotein A1 ratio and non-high-density lipoprotein cholesterol. Predictive value for CHD severity and prognostic utility in CHD patients.
Liting P; Guoping L; Zhenyue C
Herz; 2015 Mar; 40 Suppl 1():1-7. PubMed ID: 25374385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
